RHAMNUS FRANGULA (Rxhomeo Private Limited d.b.a. Rxhomeo, Inc)


Welcome to the PulseAid listing for the RHAMNUS FRANGULA drug offered from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
NON-PROPRIETARY NAME: RHAMNUS FRANGULA
SUBSTANCE NAME: FRANGULA ALNUS BARK
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-11-05
END MARKETING DATE: 0000-00-00


RHAMNUS FRANGULA HUMAN OTC DRUG Details:

Item DescriptionRHAMNUS FRANGULA from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
LABELER NAME: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 2([hp_X]/1)
START MARKETING DATE: 2015-11-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 15631-0368_9b0545dd-3e40-420a-a21e-7d8e1febd4be
PRODUCT NDC: 15631-0368
APPLICATION NUMBER:

Other FRANGULA ALNUS BARK Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Rxhomeo Private Limited d.b.a. Rxhomeo, IncRHAMNUS FRANGULA
Washington Homeopathic ProductsRhamnus frangula